Upiohn药物公司已经开始与欧洲的一些学水机构合作从事一项新的研究活动,其目标是得出有商业开发价值的产品,预期将要成立的一系列“欧洲发现中心”中的第一个已于上周由Upiohn公司,伦敦大学学院与巴黎的Paul Broca dcl’INSERM中心正式建立。Upiohn公司将为每个中心提供最多可达5年的资助,每个中心可有二十名以下的研究人员在中心所 Upiohn Pharmaceuticals is already working with a number of European water agencies on a new research initiative with the goal of deriving commercially exploitable products and is the first of a series of “European Discovery Centers” to be established Last week, it was formally established by Upiohn, University College London and the Paul Broca dcl'INSERM Center in Paris. Upiohn will provide up to five years of funding for each center, with up to 20 researchers in each center